Should You Accumulate Aptevo Therapeutics Inc (APVO) Stock Wednesday Morning?

Aptevo Therapeutics Inc (APVO) has fallen Wednesday morning, with the stock declining -16.50% in pre-market trading to 14.22. APVO's short-term technical score of 65 indicates that the stock has traded more bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, the stock ranks higher than 92% of stocks. Aptevo Therapeutics Inc has risen 19.51% over the past month, closing at $14.60 on October 27. During this period of time, the stock fell as low as $6.48 and as high as $22.08. APVO has an average analyst recommendation of Strong Buy. The company has an average price target of $52.50.

APVO has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on APVO!

See Full APVO Report

Aptevo Therapeutics Inc has a Long-Term Technical rank of 42. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 58% of the market scoring higher. In the Biotechnology industry which is number 139 by this metric, APVO ranks better than 66% of stocks.

Important Dates for Investors in APVO:

-Aptevo Therapeutics Inc is set to release earnings on 2/10/2022. During their last earnings release the company posted EPS of $-6.74. -We do not have a set dividend date for Aptevo Therapeutics Inc at this time. Click Here To Get The Full Report on Aptevo Therapeutics Inc (APVO)